In the present study, we propose a two‐stage AI‐based approach that exploits CNNs to distinguish between normal tissue and tumor tissue and to subsequently predict the mutational status of EGFR in NSCLCs, particularly for ADCs. This evidence concerns the gene EGFR and neoplasm.